Understanding differences in bioreactor lifecycle, design space, and product platforms is important for selecting a bioreactor type.
The experience gained and knowledge compiled from legacy biomanufacturing operations establish a reference. This reference can benefit a thorough assessment of new methods and technologies, and it can aid in the transition or adoption of new approaches. With respect to stainless-steel and single-use bioreactors, lifecycle, design space, and product platform concepts are discussed in this article.
Read this article in BioPharm International's Single-Use Systems 2018 eBook.
BioPharm International
eBook: Single-Use Systems 2018
Vol. 31
June 2018
Pages: 41–46
When referring to this article, please cite it as K. Clapp, "Comparing the Supply Lifecycle of Bioreactors," Single-Use Systems eBook (June 2018).
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.